Terms: = Pancreatic cancer AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP
178 results:
1. Super enhancer lncRNAs: a novel hallmark in cancer.
Song P; Han R; Yang F
Cell Commun Signal; 2024 Apr; 22(1):207. PubMed ID: 38566153
[TBL] [Abstract] [Full Text] [Related]
2. Peptidase inhibitor 16 promotes proliferation of pancreatic ductal adenocarcinoma cells through OASL signaling.
Chen Q; Jiang LY; Cao C; Liu FY; Li DR; Wu PF; Jiang KR
Mol Carcinog; 2024 May; 63(5):938-950. PubMed ID: 38353288
[TBL] [Abstract] [Full Text] [Related]
3. SiATG5-loaded cancer cell membrane-fused liposomes induced increased uptake of albumin-bound chemotherapeutics by pancreatic cancer cells.
Yan J; Wang M; Lv S; Chen D; Wu Z; Zhou D; Zhang S; Lv J; Xu K; Xu C; Wei Y
J Control Release; 2024 Mar; 367():620-636. PubMed ID: 38311244
[TBL] [Abstract] [Full Text] [Related]
4. Development of Potent Dual BET/HDAC Inhibitors via Pharmacophore Merging and Structure-Guided Optimization.
Bauer N; Balourdas DI; Schneider JR; Zhang X; Berger LM; Berger BT; Schwalm MP; Klopp NA; Siveke JT; Knapp S; Joerger AC
ACS Chem Biol; 2024 Feb; 19(2):266-279. PubMed ID: 38291964
[TBL] [Abstract] [Full Text] [Related]
5. Inhibition of Bromodomain Proteins Enhances Oncolytic HAdVC5 Replication and Efficacy in pancreatic Ductal Adenocarcinoma (PDAC) Models.
Miao T; Symonds A; Hickman OJ; Wu D; Wang P; Lemoine N; Wang Y; Linardopoulos S; Halldén G
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279262
[TBL] [Abstract] [Full Text] [Related]
6. Radiosensitizing Favors Response to Peptide Receptor Radionuclide Therapy in Patients With Highly Proliferative Neuroendocrine Malignancies: Preliminary Evidence From a Clinical Pilot Study.
Trautwein NF; Hinterleitner C; Kiefer LS; Singer S; Mattern S; Schwenck J; Reischl G; Sipos B; Lauer UM; Dittmann H; Zender L; la Fougère C; Hinterleitner M
Clin Nucl Med; 2024 Mar; 49(3):207-214. PubMed ID: 38271237
[TBL] [Abstract] [Full Text] [Related]
7. CAFs Homologous Biomimetic Liposome Bearing BET Inhibitor and Pirfenidone Synergistically Promoting Antitumor Efficacy in pancreatic Ductal Adenocarcinoma.
Zhang Y; Yu R; Zhao C; Liang J; Zhang Y; Su H; Zhao J; Wu H; Xu S; Zhang Z; Wang L; Zou X; Zhu Y; Zhang S; Lv Y
Adv Sci (Weinh); 2024 Jan; 11(1):e2305279. PubMed ID: 37968249
[TBL] [Abstract] [Full Text] [Related]
8. The Usefulness of Elastin Staining to Detect Vascular Invasion in cancer.
Gonzalez J; Bahmad HF; Ocejo S; Abreu A; Popp M; Gogola S; Fernandez V; Recine M; Poppiti R
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894944
[TBL] [Abstract] [Full Text] [Related]
9. BRD9-mediated control of the TGF-β/Activin/Nodal pathway regulates self-renewal and differentiation of human embryonic stem cells and progression of cancer cells.
Wang X; Song C; Ye Y; Gu Y; Li X; Chen P; Leng D; Xiao J; Wu H; Xie S; Liu W; Zhao Q; Chen D; Chen X; Wu Q; Chen G; Zhang W
Nucleic Acids Res; 2023 Nov; 51(21):11634-11651. PubMed ID: 37870468
[TBL] [Abstract] [Full Text] [Related]
10. Coinhibition of topoisomerase 1 and brd4-mediated pause release selectively kills pancreatic cancer via readthrough transcription.
Cameron DP; Grosser J; Ladigan S; Kuzin V; Iliopoulou E; Wiegard A; Benredjem H; Jackson K; Liffers ST; Lueong S; Cheung PF; Vangala D; Pohl M; Viebahn R; Teschendorf C; Wolters H; Usta S; Geng K; Kutter C; Arsenian-Henriksson M; Siveke JT; Tannapfel A; Schmiegel W; Hahn SA; Baranello L
Sci Adv; 2023 Oct; 9(41):eadg5109. PubMed ID: 37831776
[TBL] [Abstract] [Full Text] [Related]
11. Targeted delivery of PROTAC-based prodrug activated by bond-cleavage bioorthogonal chemistry for microneedle-assisted cancer therapy.
Huang J; Yao Z; Li B; Ping Y
J Control Release; 2023 Sep; 361():270-279. PubMed ID: 37541594
[TBL] [Abstract] [Full Text] [Related]
12. First-in-human Study of AZD5153, A Small-molecule Inhibitor of Bromodomain Protein 4, in Patients with Relapsed/Refractory Malignant Solid Tumors and Lymphoma.
Hamilton EP; Wang JS; Oza AM; Patel MR; Ulahannan SV; Bauer T; Karlix JL; Zeron-Medina J; Fabbri G; Marco-Casanova P; Moorthy G; Hattersley MM; Littlewood GM; Mitchell P; Saeh J; Pouliot GP; Moore KN
Mol Cancer Ther; 2023 Oct; 22(10):1154-1165. PubMed ID: 37486983
[TBL] [Abstract] [Full Text] [Related]
13. Arterial events in cancer patients treated with apixaban for venous thrombosis.
Larsen TL; Svalastoga M; Brekke J; Enden T; Frøen H; Garresori H; Jacobsen EM; Paulsen PQ; Porojnicu AC; Ree AH; Torfoss D; Velle EO; Wik HS; Ghanima W; Sandset PM; Dahm AEA
Thromb Res; 2023 Aug; 228():128-133. PubMed ID: 37327527
[TBL] [Abstract] [Full Text] [Related]
14. Acid sphingomyelinase expression is associated with survival in resectable pancreatic ductal adenocarcinoma.
Wilson GC; Patel SH; Wang J; Xu K; Turner KM; Becker KA; Carpinteiro A; Szabo I; Ahmad SA; Gulbins E
J Mol Med (Berl); 2023 Jul; 101(7):891-903. PubMed ID: 37246980
[TBL] [Abstract] [Full Text] [Related]
15. Pathologic Tumor Regression is Associated With Improved Survival in pancreatic cancer.
Nicolais LM; Caron M; Verdini N; Fitzgerald TL
Am Surg; 2023 Sep; 89(9):3778-3783. PubMed ID: 37227766
[TBL] [Abstract] [Full Text] [Related]
16. Optogenetic stimulation of the brainstem dorsal motor nucleus ameliorates acute pancreatitis.
Thompson DA; Tsaava T; Rishi A; Nadella S; Mishra L; Tuveson DA; Pavlov VA; Brines M; Tracey KJ; Chavan SS
Front Immunol; 2023; 14():1166212. PubMed ID: 37180135
[TBL] [Abstract] [Full Text] [Related]
17. YAP/brd4-controlled ROR1 promotes tumor-initiating cells and hyperproliferation in pancreatic cancer.
Yamazaki M; Hino S; Usuki S; Miyazaki Y; Oda T; Nakao M; Ito T; Yamagata K
EMBO J; 2023 Jul; 42(14):e112614. PubMed ID: 37096681
[TBL] [Abstract] [Full Text] [Related]
18. Ferroptosis model system by the re-expression of BACH1.
Irikura R; Nishizawa H; Nakajima K; Yamanaka M; Chen G; Tanaka K; Onodera M; Matsumoto M; Igarashi K
J Biochem; 2023 Jul; 174(3):239-252. PubMed ID: 37094356
[TBL] [Abstract] [Full Text] [Related]
19. Distinct Serum Immune Profiles Define the Spectrum of Acute and Chronic Pancreatitis From the Multicenter Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies (PROCEED) Study.
Lee B; Jones EK; Manohar M; Li L; Yadav D; Conwell DL; Hart PA; Vege SS; Fogel EL; Serrano J; Andersen D; Bellin MD; Topazian MD; Van Den Eeden SK; Pandol SJ; Forsmark CE; Fisher WE; Park WG; Husain SZ; Habtezion A;
Gastroenterology; 2023 Jul; 165(1):173-186. PubMed ID: 37061168
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic value of major pathological response following neoadjuvant therapy for non resectable pancreatic ductal adenocarcinoma.
Bao QR; Frigerio I; Tripepi M; Marletta S; Martignoni G; Giardino A; Regi P; Scopelliti F; Allegrini V; Girelli R; Pucciarelli S; Spolverato G; Butturini G
Pancreatology; 2023 Apr; 23(3):266-274. PubMed ID: 36841686
[TBL] [Abstract] [Full Text] [Related]
[Next]
